| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.33 | 0.06 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |